Literature DB >> 28510708

Aberrant White Matter Microstructure in Children and Adolescents With the Subtype of Prader-Willi Syndrome at High Risk for Psychosis.

Akvile Lukoshe1,2, Gerbrich E van den Bosch3, Aad van der Lugt4, Steven A Kushner5, Anita C Hokken-Koelega1,2, Tonya White4,6.   

Abstract

Prader-Willi Syndrome (PWS) is a complex neurogenetic disorder caused by loss of the paternal 15q11.2-q13 locus, due to deletion (DEL), maternal uniparental disomy (mUPD), or imprinting center defects. Individuals with mUPD have up to 60% risk of developing psychosis in early adulthood. Given the increasing evidence for white matter abnormalities in psychotic disorders, we investigated white matter microstructure in children and adolescents with PWS, with a particular emphasis on the DEL and mUPD subtypes. Magnetic resonance diffusion weighted images were acquired in 35 directions at 3T and analyzed using fractional anisotropy (FA), mean, axial, and radial diffusivity (MD, AD, RD) values obtained by tract-based spatial statistics (TBSS) in 28 children and adolescents with PWS and 61 controls. In addition, we employed a recently developed white matter pothole approach, which does not require local FA differences to be spatially co-localized across subjects. After accounting for age and gender, individuals with PWS had significantly lower global FA and higher MD, compared with controls. Individuals with mUPD had lower FA in multiple regions including the corpus callosum, cingulate, and superior longitudinal fasciculus and larger potholes, compared with DEL and controls. The observed differences in individuals with mUPD are similar to the white matter abnormalities in individuals with psychotic disorders. Conversely, the subtle white matter abnormalities in individuals with DEL are consistent with their substantially lower risk of psychosis. Future studies to investigate the specific neurobiological mechanism underlying the differential psychosis risk between the DEL and mUPD subtypes of PWS are highly warranted.
© The Author 2017. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  15q11–q13; Prader–Willi syndrome; neurodevelopmental disorders; psychosis; structural connectivity

Mesh:

Year:  2017        PMID: 28510708      PMCID: PMC5581891          DOI: 10.1093/schbul/sbx052

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  51 in total

1.  Prader-Willi syndrome: the psychopathological phenotype in uniparental disomy.

Authors:  W M A Verhoeven; S Tuinier; L M G Curfs
Journal:  J Med Genet       Date:  2003-10       Impact factor: 6.318

Review 2.  Regulation of oligodendrocyte differentiation and myelination.

Authors:  Ben Emery
Journal:  Science       Date:  2010-11-05       Impact factor: 47.728

3.  About "axial" and "radial" diffusivities.

Authors:  Claudia A M Wheeler-Kingshott; Mara Cercignani
Journal:  Magn Reson Med       Date:  2009-05       Impact factor: 4.668

4.  Diffusion tensor imaging in schizophrenia.

Authors:  Monte S Buchsbaum; Joseph Friedman; Bradley R Buchsbaum; King-Wai Chu; Erin A Hazlett; Randall Newmark; Jason S Schneiderman; Yuliya Torosjan; Cheuk Tang; Patrick R Hof; Daniel Stewart; Kenneth L Davis; Jack Gorman
Journal:  Biol Psychiatry       Date:  2006-08-07       Impact factor: 13.382

5.  Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study.

Authors:  Elbrich P C Siemensma; Roderick F A Tummers-de Lind van Wijngaarden; Dederieke A M Festen; Zyrhea C E Troeman; A A E M Janielle van Alfen-van der Velden; Barto J Otten; Joost Rotteveel; Roelof J H Odink; G C B Karen Bindels-de Heus; Mariette van Leeuwen; Danny A J P Haring; Wilma Oostdijk; Gianni Bocca; E C A Mieke Houdijk; A S Paul van Trotsenburg; J J Gera Hoorweg-Nijman; Hester van Wieringen; René C F M Vreuls; Petr E Jira; Eelco J Schroor; Evelyn van Pinxteren-Nagler; Jan Willem Pilon; L Bert Lunshof; Anita C S Hokken-Koelega
Journal:  J Clin Endocrinol Metab       Date:  2012-04-16       Impact factor: 5.958

6.  Fronto-temporal disconnectivity and clinical short-term outcome in first episode psychosis: a DTI-tractography study.

Authors:  David Luck; Lisa Buchy; Yvonne Czechowska; Michael Bodnar; G Bruce Pike; Jennifer S W Campbell; Amélie Achim; Ashok Malla; Ridha Joober; Martin Lepage
Journal:  J Psychiatr Res       Date:  2010-08-12       Impact factor: 4.791

7.  Diffusion tensor imaging of the superior longitudinal fasciculus and working memory in recent-onset schizophrenia.

Authors:  Katherine H Karlsgodt; Theo G M van Erp; Russell A Poldrack; Carrie E Bearden; Keith H Nuechterlein; Tyrone D Cannon
Journal:  Biol Psychiatry       Date:  2007-08-27       Impact factor: 13.382

8.  White matter 'potholes' in early-onset schizophrenia: a new approach to evaluate white matter microstructure using diffusion tensor imaging.

Authors:  Tonya White; Marcus Schmidt; Canan Karatekin
Journal:  Psychiatry Res       Date:  2009-10-22       Impact factor: 3.222

9.  Alterations in white matter evident before the onset of psychosis.

Authors:  Francesco Carletti; James B Woolley; Sagnik Bhattacharyya; Rocio Perez-Iglesias; Paolo Fusar Poli; Lucia Valmaggia; Matthew R Broome; Elvira Bramon; Louise Johns; Vincent Giampietro; Steve C R Williams; Gareth J Barker; Philip K McGuire
Journal:  Schizophr Bull       Date:  2012-04-03       Impact factor: 9.306

10.  Large recurrent microdeletions associated with schizophrenia.

Authors:  Hreinn Stefansson; Dan Rujescu; Sven Cichon; Olli P H Pietiläinen; Andres Ingason; Stacy Steinberg; Ragnheidur Fossdal; Engilbert Sigurdsson; Thordur Sigmundsson; Jacobine E Buizer-Voskamp; Thomas Hansen; Klaus D Jakobsen; Pierandrea Muglia; Clyde Francks; Paul M Matthews; Arnaldur Gylfason; Bjarni V Halldorsson; Daniel Gudbjartsson; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Asgeir Bjornsson; Sigurborg Mattiasdottir; Thorarinn Blondal; Magnus Haraldsson; Brynja B Magnusdottir; Ina Giegling; Hans-Jürgen Möller; Annette Hartmann; Kevin V Shianna; Dongliang Ge; Anna C Need; Caroline Crombie; Gillian Fraser; Nicholas Walker; Jouko Lonnqvist; Jaana Suvisaari; Annamarie Tuulio-Henriksson; Tiina Paunio; Timi Toulopoulou; Elvira Bramon; Marta Di Forti; Robin Murray; Mirella Ruggeri; Evangelos Vassos; Sarah Tosato; Muriel Walshe; Tao Li; Catalina Vasilescu; Thomas W Mühleisen; August G Wang; Henrik Ullum; Srdjan Djurovic; Ingrid Melle; Jes Olesen; Lambertus A Kiemeney; Barbara Franke; Chiara Sabatti; Nelson B Freimer; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Ole A Andreassen; Roel A Ophoff; Alexander Georgi; Marcella Rietschel; Thomas Werge; Hannes Petursson; David B Goldstein; Markus M Nöthen; Leena Peltonen; David A Collier; David St Clair; Kari Stefansson
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

View more
  3 in total

1.  Abnormal brain white matter in patients with right trigeminal neuralgia: a diffusion tensor imaging study.

Authors:  Junpeng Liu; Jiajia Zhu; Fei Yuan; Xuejun Zhang; Quan Zhang
Journal:  J Headache Pain       Date:  2018-06-22       Impact factor: 7.277

2.  The autism- and schizophrenia-associated protein CYFIP1 regulates bilateral brain connectivity and behaviour.

Authors:  Nuria Domínguez-Iturza; Adrian C Lo; Disha Shah; Marcelo Armendáriz; Anna Vannelli; Valentina Mercaldo; Massimo Trusel; Ka Wan Li; Denise Gastaldo; Ana Rita Santos; Zsuzsanna Callaerts-Vegh; Rudi D'Hooge; Manuel Mameli; Annemie Van der Linden; August B Smit; Tilmann Achsel; Claudia Bagni
Journal:  Nat Commun       Date:  2019-08-01       Impact factor: 14.919

3.  Defining Mental and Behavioural Disorders in Genetically Determined Neurodevelopmental Syndromes with Particular Reference to Prader-Willi Syndrome.

Authors:  Anthony J Holland; Lucie C S Aman; Joyce E Whittington
Journal:  Genes (Basel)       Date:  2019-12-09       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.